These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9827845)

  • 41. Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study.
    Mao X; Cheung KS; Tan JT; Mak LY; Lee CH; Chiang CL; Cheng HM; Hui RW; Yuen MF; Leung WK; Seto WK
    Gut; 2024 Jul; 73(8):1313-1320. PubMed ID: 38569845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with high levels of glycated haemoglobin in patients with type 1 diabetes: a multicentre study in Brazil.
    Andrade CS; Ribeiro GS; Santos CAST; Neves RCS; Moreira ED
    BMJ Open; 2017 Dec; 7(12):e018094. PubMed ID: 29247092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects.
    Lind M; Odén A; Fahlén M; Eliasson B
    Diabetologia; 2010 Jun; 53(6):1093-8. PubMed ID: 20237754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How are metabolic control targets of patients with Type 1 diabetes mellitus achieved in daily practice in the area with high diabetes prevalence?
    Kekäläinen P; Tirkkonen H; Laatikainen T
    Diabetes Res Clin Pract; 2016 May; 115():9-16. PubMed ID: 27242117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of random plasma glucose for assessment of glycaemic control in type 2 diabetes mellitus.
    Ain Q; Latif A; Jaffar SR; Ijaz A
    J Pak Med Assoc; 2017 Sep; 67(9):1353-1356. PubMed ID: 28924273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of glycated haemoglobin (HbA1
    Mustafa IO; Tanko Y; Yusuf R; Musa SA
    Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review.
    Pai LW; Chang PY; Chen W; Hwu YJ; Lai CH
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-20. PubMed ID: 27820154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycaemic control in a type 1 diabetes clinic for younger adults.
    Saunders SA; Wallymahmed M; MacFarlane IA
    QJM; 2004 Sep; 97(9):575-80. PubMed ID: 15317926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The trials and tribulations of determining HbA
    Klein KR; Buse JB
    Nat Rev Endocrinol; 2020 Dec; 16(12):717-730. PubMed ID: 33082551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?
    Speeckaert M; Van Biesen W; Delanghe J; Slingerland R; Wiecek A; Heaf J; Drechsler C; Lacatus R; Vanholder R; Nistor I;
    Nephrol Dial Transplant; 2014 Dec; 29(12):2167-77. PubMed ID: 24470517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of a hemoglobin A1c model in patients with type 1 and type 2 diabetes and its use to go beyond the averaged relationship of hemoglobin A1c and mean glucose level.
    Ladyzynski P; Foltynski P; Bak MI; Sabalinska S; Krzymien J; Kawiak J
    J Transl Med; 2014 Dec; 12():328. PubMed ID: 25491199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycaemic control and associated factors among patients with diabetes at public health clinics in Johor, Malaysia.
    Mahmood MI; Daud F; Ismail A
    Public Health; 2016 Jun; 135():56-65. PubMed ID: 26976488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association between long-term glycaemic control, glycaemic gap and neurological outcome of in-hospital cardiac arrest in diabetics: A retrospective cohort study.
    Wang CH; Chang JL; Huang CH; Chang WT; Tsai MS; Yu PH; Wu YW; Chen WJ; Tseng WK
    Resuscitation; 2018 Dec; 133():18-24. PubMed ID: 30261218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
    Monnier VM; Bautista O; Kenny D; Sell DR; Fogarty J; Dahms W; Cleary PA; Lachin J; Genuth S
    Diabetes; 1999 Apr; 48(4):870-80. PubMed ID: 10102706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
    Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
    Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fetal haemoglobin levels in adult type 1 (insulin-dependent) diabetic patients.
    Diem P; Mullis P; Hirt A; Schuler JJ; Bürgi W; Zuppinger KA; Teuscher A
    Diabetologia; 1993 Feb; 36(2):129-32. PubMed ID: 7681416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes.
    Phelan H; Clapin H; Bruns L; Cameron FJ; Cotterill AM; Couper JJ; Davis EA; Donaghue KC; Jefferies CA; King BR; Sinnott RO; Tham EB; Wales JK; Jones TW; Craig ME
    Med J Aust; 2017 Feb; 206(3):121-125. PubMed ID: 28208043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimation of glycaemic control in the past month using ratio of glycated albumin to HbA
    Musha I; Mochizuki M; Kikuchi T; Akatsuka J; Ohtake A; Kobayashi K; Kikuchi N; Kawamura T; Yokota I; Urakami T; Sugihara S; Amemiya S;
    Diabet Med; 2018 Jul; 35(7):855-861. PubMed ID: 29653463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss.
    Jacob S; Rabbia M; Meier MK; Hauptman J
    Diabetes Obes Metab; 2009 Apr; 11(4):361-71. PubMed ID: 19207292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.